# Lisata Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2020

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 10-K
- Filed: 2021-02-25
- Accepted by EDGAR: Feb 25, 2021, 16:08 ET
- Period: 2020-12-31
- Accession: 0000320017-21-000043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001721000043/clbs-20201231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001721000043/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2020-01-01 to 2020-12-31 | $9.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2020-01-01 to 2020-12-31 | $9.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | −$19.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | −$10.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | −$8.2m | us-gaap:NetIncomeLoss |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | −$8.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2020-01-01 to 2020-12-31 | $20.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-12-31 | $16.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-12-31 | $35.3m | us-gaap:AssetsCurrent |
| Total assets | at 2020-12-31 | $36.0m | us-gaap:Assets |
| Current liabilities | at 2020-12-31 | $3.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-12-31 | $3.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-12-31 | $32.5m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001721000043/clbs-20201231.htm

Filed Feb 25, 2021.
Source: SEC EDGAR, the filing index for accession 0000320017-21-000043. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
